Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Brands

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Medicinal Chemistry|April 28, 2020
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 KinaseVolker K Schulze, Ulrich Klar, Dirk Kosemund, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancerPhilip Wickens, Harold Kluender, Julie Dixon, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Medicinal Chemistry|April 28, 2020
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 KinaseVolker K Schulze, Ulrich Klar, Dirk Kosemund, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancerPhilip Wickens, Harold Kluender, Julie Dixon, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
Pageof 4